Announced
Completed
GANYMED PHARMACEUTICALS AG / ASTELLAS PHARMA INC. / MIG FONDS / FUTURE CAPITAL AG / ATS BETEILIGUNGSVERWALTUNG GMBH / Acquisition / Private / £395m
Financials
Transaction Value-
Consideration Type-
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Sources
Tags
treatment development
biotechnology
pharmaceuticals
Pharmaceuticals
Germany
Private
Acquisition
Completed
Friendly
Private Equity
Synopsis
Acquisition by Astellas Pharma of Ganymed Pharmaceuticals, a Germany-based pharmaceutical company engaged in developing monoclonal antibody therapeutics against solid tumors
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.